Evaluates new chalcone hybrids for anticancer activity, suggesting potential therapies.
A novel series of pyrazole/thiazole chalcone hybrids (9a–o) was designed, synthesized, and evaluated as dual tubulin/COX-2 inhibitors with anticancer activity.
No takes yet. Share an insight, caveat, or question.
SALEEM et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: